Logo image of ENOV

ENOVIS CORP (ENOV) Stock Price, Quote, News and Overview

NYSE:ENOV - New York Stock Exchange, Inc. - US1940141062 - Common Stock - Currency: USD

42.71  -1.19 (-2.71%)

After market: 42.71 0 (0%)

ENOV Quote, Performance and Key Statistics

ENOVIS CORP

NYSE:ENOV (2/21/2025, 8:15:49 PM)

After market: 42.71 0 (0%)

42.71

-1.19 (-2.71%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High63.96
52 Week Low38.27
Market Cap2.43B
Shares56.86M
Float56.31M
Yearly DividendN/A
Dividend YieldN/A
PE16.18
Fwd PE13.27
Earnings (Next)02-26 2025-02-26/amc
IPO05-08 2008-05-08


ENOV short term performance overview.The bars show the price performance of ENOV in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -2 -4 -6 -8

ENOV long term performance overview.The bars show the price performance of ENOV in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of ENOV is 42.71 USD. In the past month the price decreased by -9.65%. In the past year, price decreased by -32.04%.

ENOVIS CORP / ENOV Daily stock chart

ENOV Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 28.89 234.01B
ISRG INTUITIVE SURGICAL INC 80.74 211.07B
BSX BOSTON SCIENTIFIC CORP 41.63 154.00B
SYK STRYKER CORP 31.4 145.92B
MDT MEDTRONIC PLC 16.84 115.33B
BDX BECTON DICKINSON AND CO 16.35 65.30B
EW EDWARDS LIFESCIENCES CORP 27.98 43.23B
GEHC GE HEALTHCARE TECHNOLOGY 20.29 41.62B
IDXX IDEXX LABORATORIES INC 40.25 37.07B
DXCM DEXCOM INC 53.81 34.68B
RMD RESMED INC 26.21 34.03B
PHG KONINKLIJKE PHILIPS NVR- NY 17.5 24.02B

About ENOV

Company Profile

ENOV logo image Enovis Corp. operates as a medical technology growth company. The company is headquartered in Wilmington, Delaware and currently employs 6,550 full-time employees. The company went IPO on 2008-05-08. The company is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. The company operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity tools. The company also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions.

Company Info

ENOVIS CORP

2711 Centerville Road, Suite 400

Wilmington DELAWARE US

Employees: 6550

Company Website: https://www.enovis.com/

Investor Relations: https://ir.enovis.com/

Phone: 13022529160

ENOVIS CORP / ENOV FAQ

What is the stock price of ENOVIS CORP today?

The current stock price of ENOV is 42.71 USD. The price decreased by -2.71% in the last trading session.


What is the ticker symbol for ENOVIS CORP stock?

The exchange symbol of ENOVIS CORP is ENOV and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is ENOV stock listed?

ENOV stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for ENOVIS CORP stock?

17 analysts have analysed ENOV and the average price target is 66.3 USD. This implies a price increase of 55.23% is expected in the next year compared to the current price of 42.71. Check the ENOVIS CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ENOVIS CORP worth?

ENOVIS CORP (ENOV) has a market capitalization of 2.43B USD. This makes ENOV a Mid Cap stock.


How many employees does ENOVIS CORP have?

ENOVIS CORP (ENOV) currently has 6550 employees.


What are the support and resistance levels for ENOVIS CORP (ENOV) stock?

ENOVIS CORP (ENOV) has a support level at 38.71 and a resistance level at 44.83. Check the full technical report for a detailed analysis of ENOV support and resistance levels.


Is ENOVIS CORP (ENOV) expected to grow?

The Revenue of ENOVIS CORP (ENOV) is expected to grow by 23.86% in the next year. Check the estimates tab for more information on the ENOV EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ENOVIS CORP (ENOV) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ENOVIS CORP (ENOV) stock pay dividends?

ENOV does not pay a dividend.


When does ENOVIS CORP (ENOV) report earnings?

ENOVIS CORP (ENOV) will report earnings on 2025-02-26, after the market close.


What is the Price/Earnings (PE) ratio of ENOVIS CORP (ENOV)?

The PE ratio for ENOVIS CORP (ENOV) is 16.18. This is based on the reported non-GAAP earnings per share of 2.64 and the current share price of 42.71 USD. Check the full fundamental report for a full analysis of the valuation metrics for ENOV.


What is the Short Interest ratio of ENOVIS CORP (ENOV) stock?

The outstanding short interest for ENOVIS CORP (ENOV) is 8.88% of its float. Check the ownership tab for more information on the ENOV short interest.


ENOV Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ENOV Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to ENOV. While ENOV is still in line with the averages on profitability rating, there are concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ENOV Financial Highlights

Over the last trailing twelve months ENOV reported a non-GAAP Earnings per Share(EPS) of 2.64. The EPS increased by 13.3% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -2.15%
ROE -3.58%
Debt/Equity 0.4
Chartmill High Growth Momentum
EPS Q2Q%30.36%
Sales Q2Q%21%
EPS 1Y (TTM)13.3%
Revenue 1Y (TTM)20.52%

ENOV Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to ENOV. The Buy consensus is the average rating of analysts ratings from 17 analysts.

For the next year, analysts expect an EPS growth of 18.15% and a revenue growth 23.86% for ENOV


Ownership
Inst Owners111.54%
Ins Owners0.98%
Short Float %8.88%
Short Ratio5.93
Analysts
Analysts83.53
Price Target66.3 (55.23%)
EPS Next Y18.15%
Revenue Next Year23.86%